SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-401207
Filing Date
2014-11-06
Accepted
2014-11-06 16:57:19
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d784272d10q.htm 10-Q 604351
2 EX-10.1 d784272dex101.htm EX-10.1 13584
3 EX-31.1 d784272dex311.htm EX-31.1 8099
4 EX-31.2 d784272dex312.htm EX-31.2 8139
5 EX-32.1 d784272dex321.htm EX-32.1 4638
  Complete submission text file 0001193125-14-401207.txt   4654751

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arna-20140930.xml EX-101.INS 627164
7 XBRL TAXONOMY EXTENSION SCHEMA arna-20140930.xsd EX-101.SCH 49014
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20140930_cal.xml EX-101.CAL 65456
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20140930_def.xml EX-101.DEF 267872
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20140930_lab.xml EX-101.LAB 373626
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20140930_pre.xml EX-101.PRE 317176
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 141201548
SIC: 2834 Pharmaceutical Preparations